Q32 Bio (QTTB) Net Income towards Common Stockholders (2017 - 2025)
Q32 Bio (QTTB) has 9 years of Net Income towards Common Stockholders data on record, last reported at $45.9 million in Q4 2025.
- For Q4 2025, Net Income towards Common Stockholders rose 37.03% year-over-year to $45.9 million; the TTM value through Dec 2025 reached $18.0 million, up 28384.51%, while the annual FY2025 figure was $16.9 million, 26703.5% up from the prior year.
- Net Income towards Common Stockholders reached $45.9 million in Q4 2025 per QTTB's latest filing, up from -$7.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $92.7 million in Q1 2022 and bottomed at -$33.6 million in Q4 2021.
- Average Net Income towards Common Stockholders over 5 years is -$3.6 million, with a median of -$10.3 million recorded in 2025.
- Peak YoY movement for Net Income towards Common Stockholders: skyrocketed 8738.96% in 2022, then crashed 311.64% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$33.6 million in 2021, then grew by 1.92% to -$32.9 million in 2022, then soared by 194.67% to $31.2 million in 2023, then increased by 7.37% to $33.5 million in 2024, then surged by 37.03% to $45.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $45.9 million in Q4 2025, -$7.4 million in Q3 2025, and -$9.5 million in Q2 2025.